Biotech / Medical : QCOR Questcor Pharmaceutical


 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: Savant who wrote (43)6/13/2012 1:43:44 PM
From: senseRead Replies (1) of 82
 
And it's all still based on the market performance of the core product...

A couple years back, when it was trading around $4, they were generating good cash and using it to do some work on a couple of other products. I don't think there was anything particularly earthshaking about them... but, reformulations of existing generic chemistries that would allow them to better meet some needs...

Now, we're a few years farther along... and with adoption of the core product for more uses, the cash flow has been ramping toward increasing a bit...

Might be time to look at QCOR more closely, again, to see what sort of potential ROI on the cash they're working on delivering...

Are they still working on leveraging the resources they have created in ways that make sense ?

I've been negligent in letting this thing drift this long without keeping up on the DD...
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2013 Knight Sac Media. All rights reserved.